dihexa renal toxicity study adverse effects kidney For patients with myotonic dystrophy type 1 ― a rare, dominantly inherited, progressive disorder that affects multiple organ systems and results in decreased life expectancy ― there are Dihexa | 1401708-83-5 | BGC70883
Dihexa 1401708 83 5 BGC70883 Biosynth Pathway based network medicine identifies novel natural products for Alzheimer's disease Alzheimer's Research & Therapy Springer Nature Link Nephrotoxicity evaluation and proteomic analysis in kidneys of rats exposed to thioacetamide Scientific Reports Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A SingleDose Phase 1 Study Mittur 2026 Clinical Pharmacology in Drug Development Wiley Online Library Plasma cadmium is associated with increased risk of long term kidney graft failure Kidney International For patients with myotonic dystrophy type 1 a rare, dominantly inherited, progressive disorder that affects multiple organ systems and results in decreased life expectancy there are currently no approved therapies.
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




